Stock Events

Stock Events

Sirona Biochem 

$0.005100
14
-$0.00-0% Thursday 20:00

Statistics

Day High
0.0121
Day Low
0.0115
52W High
0.0213
52W Low
0.0001
Volume
50,000
Avg. Volume
0
Mkt Cap
1.32M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

29SepExpected
Q2 2020
Q4 2020
Q1 2021
Q2 2021
Q4 2021
Q1 2022
Q2 2022
-0.01
-0.01
-0
-0
Expected EPS
N/A
Actual EPS
-0.0012

Financials

-7,116.49%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
26,476.89Revenue
-1.88MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
L`Oreal
LRLCY
Mkt Cap231.01B
L'Oréal operates in the beauty and skincare sector, directly competing with Sirona Biochem's cosmetic ingredient development.
Estee Lauder Cos.
EL
Mkt Cap29.91B
Estée Lauder competes in the development and marketing of skincare, makeup, fragrance, and hair care products, similar to Sirona's focus areas.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson, through its consumer health division, competes in the skincare market, particularly in the development of beauty and personal care products.
Procter & Gamble
PG
Mkt Cap342.4B
Procter & Gamble competes across various segments including skincare and personal care, overlapping with Sirona Biochem's market.
Unitedhealth Group
UNH
Mkt Cap385.62B
Unilever, with its vast portfolio of personal care and beauty brands, competes in the same market as Sirona Biochem.
Colgate-Palmolive
CL
Mkt Cap73.81B
Colgate-Palmolive, through its personal care products, competes in the oral and skin care markets, relevant to Sirona's interests.
Kimberly-Clark
KMB
Mkt Cap37.31B
Kimberly-Clark, with products in the personal care segment, competes indirectly by offering skincare products.
GSK
GSK
Mkt Cap105.71B
GlaxoSmithKline, through its consumer healthcare division, competes in the oral health and nutritional products market, indirectly competing with Sirona.
Novartis
NVS
Mkt Cap293.94B
Novartis, a pharmaceutical company, competes indirectly through its dermatology division, focusing on skin conditions that could overlap with Sirona's cosmetic ingredient innovations.

About

Sirona Biochem Corp. operates as a biotechnology company dedicated to uncovering and commercializing active ingredients for both cosmetic and pharmaceutical uses, with a commercial presence in Canada and France. Key initiatives include the development of a cosmetic skin brightener and a pharmaceutical solution for diabetes. Beyond these, the company is engaged in several other projects, such as building a library of anti-aging and cell-protective compounds, creating a novel anti-wrinkle agent, and pursuing an antiviral research program. A notable collaboration exists with the International Centre for Genetic Engineering and Biotechnology (ICGEB) for the joint development of an antiviral compound library. Established in 2006, the business, originally named High Rider Capital Inc., rebranded as Sirona Biochem Corp. in May 2009 and maintains its headquarters in Vancouver, Canada.
Show more...
CEO
Dr. Howard J. Verrico M.D., Ph.D.
Employees
10
Country
Canada
ISIN
CA82967M1005

Listings

STU
DE
ZSB.STU
OTC Link
US
SRBCF

0 Comments

Share your thoughts

FAQ

What is Sirona Biochem stock price today?▼
The current price of SRBCF is $0.01 USD — it has decreased by -0% in the past 24 hours. Watch Sirona Biochem stock price performance more closely on the chart.
What is Sirona Biochem stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Sirona Biochem stocks are traded under the ticker SRBCF.
Is Sirona Biochem stock price growing?▼
SRBCF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Sirona Biochem has showed a -71.82% decrease.
What is Sirona Biochem market cap?▼
Today Sirona Biochem has the market capitalization of 1.32M
What were Sirona Biochem earnings last quarter?▼
SRBCF earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Sirona Biochem revenue for the last year?▼
Sirona Biochem revenue for the last year amounts to 26,476.89 USD.
What is Sirona Biochem net income for the last year?▼
SRBCF net income for the last year is -1.88M USD.
How many employees does Sirona Biochem have?▼
As of July 28, 2026, the company has 10 employees.
In which sector is Sirona Biochem located?▼
Sirona Biochem operates in the Health & Wellness sector.
When did Sirona Biochem complete a stock split?▼
Sirona Biochem has not had any recent stock splits.
Where is Sirona Biochem headquartered?▼
Sirona Biochem is headquartered in Vancouver, Canada.